期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Circulating neuroendocrine tumors biomarkers.Why?When?How?Suggestions for clinical practice from guidelines and consensus
1
作者 Paola Razzore giorgio arnaldi 《Journal of Cancer Metastasis and Treatment》 CAS 2016年第1期348-356,共9页
Neuroendocrine neoplasms(NETs)are rare tumors that are increasing in incidence.NETs are characterized by heterogeneous biological behaviour,clinical presentation and course.A sensitive and specific diagnostic and prog... Neuroendocrine neoplasms(NETs)are rare tumors that are increasing in incidence.NETs are characterized by heterogeneous biological behaviour,clinical presentation and course.A sensitive and specific diagnostic and prognostic circulating biomarker useful for all sites,grading and staging of neuroendocrine tumors is still an unmet need.The aim of this article was to review current neuroendocrine and oncologic scientific society guidelines and position statements,and propose recommendations for the most frequent clinical practice queries on circulating neuroendocrine tumors biomarkers.The authors searched for NCCN,NANETS,ESMO,ENETS,UKINETS,AME management guidelines or position statements available from PubMed up to 7th January 2016.From these results we chose guidelines or position statements published by scientific societies or institutions in USA,Europe and Italy with recognized expertise in neuroendocrine tumor patient management.The authors present suggestions for clinical practice based on this analysis. 展开更多
关键词 Neuroendocrine tumors neuroendocrine markers neuroendocrine management chromogranin A GUIDELINES clinical practice
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部